Immunophenotypes in adult acute lymphocytic leukemia. Role of flow cytometry in diagnosis and monitoring of disease

Hematology/Oncology Clinics of North America

Volumn 14, Issue 6, 2000, Pages 1251-1265

  Huh, Yang O ^b   Ibrahim, Sherif ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; MONOCLONAL ANTIBODY; ONCOPROTEIN; TUMOR MARKER;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; APOPTOSIS; CANCER CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL SELECTION; DIAGNOSTIC VALUE; DRUG RESISTANCE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIETIC CELL; HUMAN; IMMUNOPHENOTYPING; MINIMAL RESIDUAL DISEASE; MOLECULAR PROBE; MORPHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW;

EID: 0033638635     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70185-4     Document Type: Article

References (55)

1. Myeloperoxidase antigen expression in adult acute lymphoblastic leukemia
2. Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemia with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangements
3. Proposal for the immunologic classification of acute leukemia
4. The morphological classification of acute lymphoblastic leukemia: Concordance among observance and clinical correlation
5. Proposals for the classification of acute leukemias
6. Proposal for the recognition of minimally differentiated acute myeloid leukemia (AML-M0)
7. Immunophenotyping of acute leukemia by flow cytometry: Use of CD45 and right angle light scatter to gate on leukemic blasts in three-color analysis
8. Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters and outcome: An analysis of a prospective trial including 562 tested patients
9. Quality control of multidrug resistance assay in adult acute leukemia: Correlation between assays for p-glycoprotein expression and activity
10. Lineage commitment in biphenotypic acute leukemia
11. Measurement of apoptotic cells in peripheral blood
12. Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B ALL
13. The biology and treatment of acute lymphoblastic leukemia in adults
14. The detection of residual acute lymphoblastic leukemia cells with immunologic methods and polymerase chain reaction: A comparative study
15. Detection of minimal residual disease in acute leukemia: Methodological advances and clinical significance
16. Immunophenotypic diagnosis by using decision tree induction
17. Features of apoptotic cells measured by flow cytometry
18. Immunodiagnosis of acute leukemia displaying ectopic antigens
19. Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease
20. G-CSF, GM-CSF, SCF, PIXY-321, IL-3, and IL-7: Receptor binding and effects on clonogenic growth in acute lymphoblastic leukemia (ALL)
21. Review of incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia
22. Quantitative flow cytometry can distinguish between normal and leukemic B-cell precursors
23. Detection of minimal residual disease in B-lineage acute lymphoblastic leukemia by quantitative flow cytometry
24. Morphological and cytochemical findings in 150 cases of T-lineage of acute lymphoblastic leukemia in adults
25. Study of CD3-associated T-cell receptors reveals further differences between T-cell leukemia and acute lymphoblastic leukemia and lymphoma
26. Detection of rare cells at a frequency of one per million by flow cytometry
27. Acute biphenotypic leukeima: Immunophenotypic and cytogenetic analysis
28. Classification of adult acute lymphocytic leukemia by immuophenotypes
29. c-kit in leukemia and myelodysplasia as detected by monocloanl antibodies
30. Terminal deoxynucleotidyl transferase expression in acute myelogenous leukemia and myelodysplasia as determined by flow cytometry
31. Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells
32. Asynchronous antigen expression in B lineage acute lymphoblastic leukemia
33. Mixed-lineage leukemia revisited: Acute lymphoblastic leukemia with myeloperoxidase-positive blasts by electron microscopy
34. Leucocyte typing VI: White cell differentiation antigens
35. Continuous cultures of fused cells secreting antibody of predefined specificity
36. Flow cytometric monitoring of cellular anthracycline accumulation in murine leukemic cells
37. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 8811
38. Flow cytometric analysis of human bone marrow II: Normal B lymphocyte development
39. Clinical importance of T-ALL subclassification according to thymic and prethymic maturation stage
40. Definition of acute biphenotypic leukemia
41. A novel monoclonal antibody, KOR-SA3544, which reacts to Philadelphia chromosome-positive acute lymphoblastic leukemia cells with high sensitivity
42. Detection of terminal transferase in acute myeloid leukemia by flow cytometry
43. Characteristics and outcome of patients with acute lymphocytic leukemia and myeloperoxidase-positive blasts by electron microscopy
44. Myeloid markers in adult acute lymphocytic leukemia
45. Discrete stages of intrathymic differentiation: Analysis of normal thymocyte and leukemic lymphoblasts of T lineage
46. A case of mature B-cell ALL with coexistance of t(1;19) and t(14;18) and expression of the E2A/PBX1 fusion gene
47. Monoclonal antibodies specific to the acute lymphoblastic leukemia t(1:19)-associated E2A/pbx1 chimeric protein: Characterization and diagnostic utility
48. Immunophenotypic and clinical features of T-cell receptor gamma delta + T-lineage acute lymphoblastic leukemia
49. Development of clinical standards for flow cytometry
50. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia
51. Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodies
52. Prethymic phenotype and genotype of pre-T (CD7+/ER-) cell leukemia and its clinical significance within adult lymphoblastic leukemia
53. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction
54. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia in childhood
55. Acute lymphoblastic leukemia with myeloperoxidase activity